Age
Item
age > 21 year-old
boolean
C0001779 (UMLS CUI [1])
Idiopathic intracranial hypertension
Item
established diagnosis of idiopathic intracranial hypertension according to the criteria of the 2004 international classification of headache disorders
boolean
C0033845 (UMLS CUI [1])
Visual Impairment Grade Humphrey Visual Field Analyzer
Item
severe visual function loss, defined as grades 4 and 5 on the humphrey visual field analyzer sita standard 24-2 test grading scale
boolean
C3665347 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C2721095 (UMLS CUI [1,3])
Acetazolamide Dose failed | Diamox Dose failed | Acetazolamide Maximum Tolerated Dose failed | Diamox Maximum Tolerated Dose failed
Item
failure of treatment with acetazolamide (diamox) given at efficient dose (2g/d or maximum tolerated dose). failure is defined by the absence of visual function improvement after 1 month of treatment and/or medication intolerance.
boolean
C0000981 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0591362 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0000981 (UMLS CUI [3,1])
C0752079 (UMLS CUI [3,2])
C0231175 (UMLS CUI [3,3])
C0591362 (UMLS CUI [4,1])
C0752079 (UMLS CUI [4,2])
C0231175 (UMLS CUI [4,3])
Topiramate Dose U/day failed | Topamax Dose U/day failed | Intolerance to Pharmaceutical Preparations
Item
failure of treatment with topiramate (topamax) given at efficient dose (maximum 150mg daily). failure is defined by the absence of visual function improvement after 1 month of treatment and/or medication intolerance.
boolean
C0076829 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0723778 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0456683 (UMLS CUI [2,3])
C0231175 (UMLS CUI [2,4])
C1744706 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
MRI venography | Computed tomography venography | Sinus Transverse Stenosis Bilateral | Sinus Transverse Stenosis Unilateral | Sinus Transverse Hypoplasia Contralateral | Sinus Transverse Atresia Contralateral | Sinus Lumen Diameter Reduction
Item
magnetic resonance venography (mrv) or computed tomography venography (ctv) demonstrating bilateral transverse sinus stenosis or unilateral transverse sinus stenosis with contralateral transverse sinus hypoplasia or atresia. at least one of the stenoses must cause ≥ 50% reduction of the sinus lumen diameter.
boolean
C1690005 (UMLS CUI [1])
C2317140 (UMLS CUI [2])
C0226504 (UMLS CUI [3,1])
C0205106 (UMLS CUI [3,2])
C1261287 (UMLS CUI [3,3])
C0238767 (UMLS CUI [3,4])
C0226504 (UMLS CUI [4,1])
C0205106 (UMLS CUI [4,2])
C1261287 (UMLS CUI [4,3])
C0205092 (UMLS CUI [4,4])
C0226504 (UMLS CUI [5,1])
C0205106 (UMLS CUI [5,2])
C0243069 (UMLS CUI [5,3])
C0441988 (UMLS CUI [5,4])
C0226504 (UMLS CUI [6,1])
C0205106 (UMLS CUI [6,2])
C0243066 (UMLS CUI [6,3])
C0441988 (UMLS CUI [6,4])
C0226504 (UMLS CUI [7,1])
C1301906 (UMLS CUI [7,2])
C1301886 (UMLS CUI [7,3])
C0392756 (UMLS CUI [7,4])
Informed Consent
Item
signed informed consent obtained from the patient.
boolean
C0021430 (UMLS CUI [1])
Iodine contrast allergy Severe | Premedication Steroids
Item
severe allergic reaction to iodine contrast despite pre-medication with steroids.
boolean
C4022917 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0033045 (UMLS CUI [2,1])
C0038317 (UMLS CUI [2,2])
Renal Insufficiency | Creatinine measurement, serum | Creatinine clearance measurement
Item
renal function impairment:creatinine >1.5 mg/dl, and/or creatinine clearance <60 ml/min
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
Medical contraindication General Anesthesia
Item
contraindication to general anesthesia.
boolean
C1301624 (UMLS CUI [1,1])
C0002915 (UMLS CUI [1,2])
Medical contraindication Aspirin | Medical contraindication Clopidogrel | Medical contraindication Plavix | Medical contraindication Anticoagulants
Item
contraindication to aspirin, clopidogrel (plavix®) or anticoagulants.
boolean
C1301624 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0633084 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0003280 (UMLS CUI [4,2])
Thrombophilia | Antiphospholipid Syndrome | Tetracycline To be stopped | Oral Contraceptives To be stopped | Vitamin A To be stopped
Item
patients with thrombophilic disorders and anti-cardiolipin syndrome will be excluded from the study. patients using tetracycline, oral contraceptives or vitamin a, can only be included 3 months after discontinuing these agents.
boolean
C0398623 (UMLS CUI [1])
C0085278 (UMLS CUI [2])
C0039644 (UMLS CUI [3,1])
C1272691 (UMLS CUI [3,2])
C0009905 (UMLS CUI [4,1])
C1272691 (UMLS CUI [4,2])
C0042839 (UMLS CUI [5,1])
C1272691 (UMLS CUI [5,2])
Dural Arteriovenous Fistula | Lesion Arteriovenous | Involvement with Cortical flow in veins
Item
patients with dural arteriovenous fistula (davf) or other arteriovenous lesion affecting cortical venous flow will be excluded from the protocol.
boolean
C0752156 (UMLS CUI [1])
C0221198 (UMLS CUI [2,1])
C0450109 (UMLS CUI [2,2])
C1314939 (UMLS CUI [3,1])
C0425705 (UMLS CUI [3,2])
C0007776 (UMLS CUI [3,3])
Shunt malfunction | Cerebrospinal Fluid Diversion
Item
acute shunt dysfunction in patients with prior csf diversion procedure.
boolean
C0948276 (UMLS CUI [1])
C0007806 (UMLS CUI [2,1])
C0185033 (UMLS CUI [2,2])
Pregnancy | Childbearing Potential Contraceptive methods Absent
Item
pregnancy or absence of contraception in woman of childbearing potential.
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])